UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$494M |
| 2 |
Johnson & Johnson
JNJ
|
+$466M |
| 3 |
Procter & Gamble
PG
|
+$299M |
| 4 |
Amazon
AMZN
|
+$285M |
| 5 |
Advanced Micro Devices
AMD
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$510M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$315M |
| 4 |
Intel
INTC
|
+$227M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.22% |
| 2 | Healthcare | 12.65% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Financials | 11.23% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Universal Insurance Holdings
UVE
$1.23B
| $385K | ﹤0.01% |
24,075
+3,179
| +15% | +$49.5K |
|
|
SPNS
2327
DELISTED
Sapiens International
SPNS
| $382K | ﹤0.01% |
13,207
| – | – |
|
|
SNPO
2328
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $381K | ﹤0.01% |
42,734
| – | – |
|
|
AGEN
2329
Agenus
AGEN
$290M
| $376K | ﹤0.01% |
22,714
| – | – |
|
2330
Thryv Holdings
THRY
$108M
| $375K | ﹤0.01% |
18,447
+6,747
| +58% | +$127K |
|
2331
Mitek Systems
MITK
$834M
| $370K | ﹤0.01% |
28,399
| – | – |
|
2332
Zai Lab
ZLAB
$2.62B
| $368K | ﹤0.01% |
13,466
+148
| +1% | +$3.91K |
|
2333
ARKO Corp
ARKO
$635M
| $365K | ﹤0.01% |
44,223
+6,841
| +18% | +$52.4K |
|
2334
AnaptysBio
ANAB
$1.68B
| $362K | ﹤0.01% |
16,921
| – | – |
|
2335
Pulmonx
LUNG
$87.6M
| $358K | ﹤0.01% |
28,068
| – | – |
|
2336
Smith & Wesson
SWBI
$637M
| $356K | ﹤0.01% |
26,243
| – | – |
|
|
SFIX
2337
Stitch Fix
SFIX
$560M
| $354K | ﹤0.01% |
99,294
+9,256
| +10% | +$32.7K |
|
2338
NextDecade
NEXT
$1.78B
| $352K | ﹤0.01% |
73,814
+7,011
| +10% | +$32.6K |
|
2339
Cogent Biosciences
COGT
$7.24B
| $350K | ﹤0.01% |
59,557
+7,900
| +15% | +$60.5K |
|
2340
Enel Chile
ENIC
$6.28B
| $348K | ﹤0.01% |
107,316
| – | – |
|
2341
Pagaya Technologies
PGY
$1.78B
| $346K | ﹤0.01% |
+20,890
| New | +$341K |
|
2342
1st Source
SRCE
$2.12B
| $346K | ﹤0.01% |
6,289
| – | – |
|
2343
Children's Place
PLCE
$59.8M
| $343K | ﹤0.01% |
14,752
+3,218
| +28% | +$78.3K |
|
2344
Seneca Foods Class A
SENEA
$1.21B
| $341K | ﹤0.01% |
6,500
| – | – |
|
2345
Novavax
NVAX
$1.31B
| $340K | ﹤0.01% |
70,793
-29,421
| -29% | -$180K |
|
2346
Dyne Therapeutics
DYN
$4.9B
| $338K | ﹤0.01% |
25,389
+13,167
| +108% | +$129K |
|
|
EWCZ
2347
DELISTED
European Wax Center
EWCZ
| $337K | ﹤0.01% |
24,829
| – | – |
|
2348
Clearfield
CLFD
$374M
| $337K | ﹤0.01% |
11,579
+3,366
| +41% | +$89.7K |
|
2349
Powell Industries
POWL
$7.71B
| $337K | ﹤0.01% |
+11,421
| New | +$318K |
|
2350
MetroCity Bankshares
MCBS
$1.03B
| $336K | ﹤0.01% |
14,000
| – | – |
|
Similar funds
UBS AM's Q4 2023 Portfolio in Review
As of Q4 2023, UBS AM held 2,644 positions worth $254B, up 14% from $223B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM's Q4 2023 filing shows 62 new, 1,338 increased, 675 reduced and 106 closed positions. Its largest new stake was Veralto: 1,187,566 shares worth $97.7M. The largest sale was VMware, Inc, an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- UBS AM's largest Q4 2023 buy was Veralto: 1,187,566 shares worth $97.7M.
- UBS AM added most to Broadcom in Q4 2023, an estimated $494M increase.
- UBS AM's biggest Q4 2023 reduction was Microsoft, cutting an estimated $315M.
- UBS AM fully exited VMware, Inc in Q4 2023, selling an estimated $510M.
- UBS AM's ten largest holdings make up 26% of its $254B portfolio in Q4 2023.
- UBS AM opened 62 new positions and closed 106 in Q4 2023.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $254B.
Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.